| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 121 | 2022 | 7165 | 4.290 |
Why?
|
| Dementia | 35 | 2022 | 2227 | 3.190 |
Why?
|
| Apolipoprotein E4 | 15 | 2022 | 611 | 1.810 |
Why?
|
| Apolipoproteins E | 25 | 2022 | 1465 | 1.710 |
Why?
|
| Cognition Disorders | 33 | 2017 | 3956 | 1.580 |
Why?
|
| Flavonoids | 2 | 2021 | 421 | 1.430 |
Why?
|
| Genetic Linkage | 21 | 2008 | 2521 | 1.340 |
Why?
|
| Cognition | 18 | 2022 | 5982 | 1.180 |
Why?
|
| Neuropsychological Tests | 38 | 2022 | 6879 | 1.120 |
Why?
|
| Amyloid beta-Peptides | 10 | 2019 | 3167 | 0.910 |
Why?
|
| alpha-Macroglobulins | 5 | 2007 | 63 | 0.830 |
Why?
|
| Genotype | 30 | 2020 | 12863 | 0.700 |
Why?
|
| Brain | 25 | 2022 | 24969 | 0.680 |
Why?
|
| Leukoaraiosis | 1 | 2018 | 137 | 0.600 |
Why?
|
| Aged | 128 | 2022 | 161488 | 0.570 |
Why?
|
| Cerebrovascular Disorders | 4 | 2021 | 1508 | 0.520 |
Why?
|
| Cholinesterase Inhibitors | 4 | 2013 | 231 | 0.510 |
Why?
|
| Microvessels | 1 | 2018 | 565 | 0.500 |
Why?
|
| Inheritance Patterns | 3 | 2013 | 344 | 0.490 |
Why?
|
| Stroke | 11 | 2021 | 9256 | 0.480 |
Why?
|
| Psychiatric Status Rating Scales | 13 | 2017 | 6190 | 0.470 |
Why?
|
| Diet | 4 | 2022 | 7392 | 0.460 |
Why?
|
| Aged, 80 and over | 76 | 2022 | 58184 | 0.450 |
Why?
|
| Polymorphism, Genetic | 12 | 2009 | 4293 | 0.450 |
Why?
|
| Genetic Testing | 13 | 2019 | 3303 | 0.440 |
Why?
|
| Antipsychotic Agents | 5 | 2022 | 3033 | 0.440 |
Why?
|
| Humans | 207 | 2022 | 708843 | 0.430 |
Why?
|
| Genetic Predisposition to Disease | 32 | 2019 | 17218 | 0.420 |
Why?
|
| Longitudinal Studies | 29 | 2021 | 13536 | 0.410 |
Why?
|
| Apolipoprotein E2 | 2 | 2007 | 133 | 0.400 |
Why?
|
| Models, Statistical | 10 | 2021 | 5034 | 0.390 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 962 | 0.380 |
Why?
|
| Caregivers | 8 | 2021 | 1906 | 0.370 |
Why?
|
| Lod Score | 10 | 2011 | 617 | 0.370 |
Why?
|
| Male | 124 | 2022 | 349524 | 0.370 |
Why?
|
| Female | 126 | 2022 | 375205 | 0.360 |
Why?
|
| Nuclear Family | 7 | 2006 | 310 | 0.360 |
Why?
|
| Interview, Psychological | 3 | 2011 | 837 | 0.360 |
Why?
|
| Diet Surveys | 3 | 2022 | 1157 | 0.360 |
Why?
|
| Indans | 2 | 2006 | 101 | 0.340 |
Why?
|
| Age of Onset | 21 | 2015 | 3330 | 0.340 |
Why?
|
| Peptide Fragments | 3 | 2018 | 5141 | 0.330 |
Why?
|
| Hypertension | 3 | 2020 | 8161 | 0.330 |
Why?
|
| Temporal Lobe | 8 | 2017 | 1655 | 0.330 |
Why?
|
| Chromosome Mapping | 11 | 2011 | 4837 | 0.320 |
Why?
|
| Memory | 5 | 2020 | 2154 | 0.310 |
Why?
|
| Gene Frequency | 14 | 2017 | 3701 | 0.300 |
Why?
|
| Models, Genetic | 9 | 2011 | 3539 | 0.290 |
Why?
|
| Cerebral Hemorrhage | 4 | 2022 | 2518 | 0.290 |
Why?
|
| Lipid Metabolism | 2 | 2019 | 1999 | 0.280 |
Why?
|
| Social Participation | 3 | 2021 | 162 | 0.270 |
Why?
|
| Aging | 11 | 2019 | 8358 | 0.270 |
Why?
|
| Interviews as Topic | 1 | 2012 | 2571 | 0.270 |
Why?
|
| Cohort Studies | 29 | 2022 | 39292 | 0.260 |
Why?
|
| Activities of Daily Living | 7 | 2021 | 2320 | 0.260 |
Why?
|
| Risk Factors | 35 | 2022 | 69553 | 0.250 |
Why?
|
| Emergency Medical Services | 1 | 2014 | 1746 | 0.250 |
Why?
|
| Delirium | 3 | 2022 | 1447 | 0.240 |
Why?
|
| Chromosomes, Human | 3 | 2011 | 475 | 0.240 |
Why?
|
| Magnetic Resonance Imaging | 25 | 2022 | 34151 | 0.240 |
Why?
|
| Cerebral Amyloid Angiopathy | 3 | 2017 | 752 | 0.240 |
Why?
|
| Pedigree | 11 | 2015 | 4724 | 0.240 |
Why?
|
| Middle Aged | 61 | 2022 | 213752 | 0.240 |
Why?
|
| Anticonvulsants | 3 | 2021 | 1840 | 0.240 |
Why?
|
| Disease Progression | 17 | 2021 | 13298 | 0.240 |
Why?
|
| Blood Pressure | 5 | 2021 | 8528 | 0.230 |
Why?
|
| Bipolar Disorder | 7 | 2006 | 5023 | 0.230 |
Why?
|
| Polymorphism, Single Nucleotide | 18 | 2018 | 15485 | 0.230 |
Why?
|
| Linkage Disequilibrium | 13 | 2017 | 2062 | 0.220 |
Why?
|
| Genetic Loci | 3 | 2019 | 2587 | 0.220 |
Why?
|
| Exercise | 1 | 2018 | 5251 | 0.220 |
Why?
|
| Depression | 7 | 2019 | 7202 | 0.220 |
Why?
|
| International Classification of Diseases | 3 | 2022 | 844 | 0.210 |
Why?
|
| Epilepsy | 4 | 2020 | 2892 | 0.210 |
Why?
|
| Haplotypes | 6 | 2020 | 2874 | 0.210 |
Why?
|
| Meat Products | 1 | 2021 | 85 | 0.210 |
Why?
|
| Memantine | 2 | 2013 | 100 | 0.210 |
Why?
|
| Infarction | 1 | 2022 | 223 | 0.210 |
Why?
|
| Mental Recall | 5 | 2014 | 1195 | 0.210 |
Why?
|
| Educational Status | 5 | 2022 | 2278 | 0.210 |
Why?
|
| United States | 34 | 2022 | 67165 | 0.210 |
Why?
|
| National Institute of Mental Health (U.S.) | 5 | 2011 | 104 | 0.200 |
Why?
|
| Vitamin E | 1 | 2005 | 842 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 10 | 4 | 2007 | 291 | 0.200 |
Why?
|
| Genetics, Medical | 2 | 2005 | 319 | 0.190 |
Why?
|
| Medicare | 8 | 2022 | 5691 | 0.190 |
Why?
|
| Entorhinal Cortex | 3 | 2017 | 251 | 0.190 |
Why?
|
| Piperidines | 2 | 2006 | 1582 | 0.190 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2012 | 1306 | 0.190 |
Why?
|
| Alleles | 13 | 2020 | 7090 | 0.190 |
Why?
|
| Neurofibrillary Tangles | 2 | 2021 | 421 | 0.190 |
Why?
|
| Quantitative Trait Loci | 4 | 2011 | 1976 | 0.180 |
Why?
|
| Parietal Lobe | 3 | 2008 | 818 | 0.180 |
Why?
|
| Genetic Markers | 10 | 2009 | 2690 | 0.180 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2000 | 292 | 0.180 |
Why?
|
| Nerve Fibers, Myelinated | 3 | 2011 | 991 | 0.180 |
Why?
|
| Predictive Value of Tests | 13 | 2017 | 15252 | 0.180 |
Why?
|
| tau Proteins | 2 | 2019 | 1623 | 0.170 |
Why?
|
| Genome-Wide Association Study | 10 | 2019 | 11738 | 0.170 |
Why?
|
| Proportional Hazards Models | 11 | 2017 | 12292 | 0.170 |
Why?
|
| Alcoholism | 4 | 2004 | 1840 | 0.170 |
Why?
|
| Cross-Sectional Studies | 15 | 2021 | 23020 | 0.170 |
Why?
|
| Mental Status Schedule | 7 | 2014 | 313 | 0.170 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2017 | 3026 | 0.170 |
Why?
|
| Leukoencephalopathies | 1 | 2021 | 252 | 0.170 |
Why?
|
| Electronic Health Records | 5 | 2022 | 4173 | 0.170 |
Why?
|
| Case-Control Studies | 15 | 2020 | 21194 | 0.160 |
Why?
|
| Age Factors | 11 | 2021 | 18712 | 0.160 |
Why?
|
| Phospholipase C gamma | 1 | 2017 | 128 | 0.160 |
Why?
|
| Geriatric Assessment | 4 | 2016 | 1309 | 0.160 |
Why?
|
| Atrophy | 8 | 2017 | 1509 | 0.160 |
Why?
|
| Preoperative Care | 2 | 2017 | 2357 | 0.160 |
Why?
|
| Research Design | 6 | 2021 | 5833 | 0.160 |
Why?
|
| Nootropic Agents | 2 | 2010 | 162 | 0.160 |
Why?
|
| Genome, Human | 4 | 2008 | 4493 | 0.150 |
Why?
|
| Olfactory Perception | 1 | 2016 | 54 | 0.150 |
Why?
|
| Fibrinolytic Agents | 2 | 2012 | 2129 | 0.150 |
Why?
|
| Family | 9 | 2008 | 3087 | 0.150 |
Why?
|
| Netherlands | 2 | 2020 | 2068 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 1997 | 252 | 0.150 |
Why?
|
| Dietary Proteins | 1 | 2022 | 967 | 0.150 |
Why?
|
| Early Diagnosis | 1 | 2021 | 1192 | 0.150 |
Why?
|
| Plaque, Amyloid | 3 | 2016 | 673 | 0.150 |
Why?
|
| Demography | 4 | 2014 | 1596 | 0.150 |
Why?
|
| Exons | 3 | 2001 | 2472 | 0.150 |
Why?
|
| Memory Disorders | 5 | 2011 | 1139 | 0.150 |
Why?
|
| Metformin | 1 | 2022 | 800 | 0.150 |
Why?
|
| Decision Support Techniques | 2 | 2021 | 2029 | 0.140 |
Why?
|
| Algorithms | 11 | 2022 | 13647 | 0.140 |
Why?
|
| Cardiovascular Diseases | 5 | 2015 | 14075 | 0.140 |
Why?
|
| Lewy Body Disease | 2 | 2008 | 202 | 0.140 |
Why?
|
| Calcium-Binding Proteins | 1 | 2000 | 1101 | 0.140 |
Why?
|
| Amyloid | 3 | 2022 | 710 | 0.140 |
Why?
|
| Abbreviations as Topic | 1 | 2014 | 9 | 0.140 |
Why?
|
| Cost of Illness | 3 | 2014 | 1820 | 0.140 |
Why?
|
| Cerebral Cortex | 5 | 2011 | 5703 | 0.140 |
Why?
|
| Reproducibility of Results | 11 | 2022 | 19423 | 0.140 |
Why?
|
| Remote Consultation | 1 | 1997 | 252 | 0.130 |
Why?
|
| Amyloidosis | 1 | 2022 | 788 | 0.130 |
Why?
|
| Hippocampus | 6 | 2016 | 3639 | 0.130 |
Why?
|
| Follow-Up Studies | 17 | 2022 | 39038 | 0.130 |
Why?
|
| Antisocial Personality Disorder | 2 | 2006 | 239 | 0.130 |
Why?
|
| Reference Values | 5 | 2008 | 5041 | 0.130 |
Why?
|
| Depressive Disorder | 5 | 2019 | 3811 | 0.130 |
Why?
|
| Seizures | 2 | 2021 | 2562 | 0.130 |
Why?
|
| Odds Ratio | 8 | 2022 | 9754 | 0.130 |
Why?
|
| Telephone | 1 | 1997 | 624 | 0.130 |
Why?
|
| Social Behavior Disorders | 1 | 2014 | 96 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 12 | 4 | 2007 | 462 | 0.120 |
Why?
|
| Telomere | 1 | 2019 | 823 | 0.120 |
Why?
|
| Dementia, Vascular | 1 | 2014 | 116 | 0.120 |
Why?
|
| Conduct Disorder | 2 | 2006 | 256 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 9 | 4 | 2009 | 547 | 0.120 |
Why?
|
| Pancreatitis, Alcoholic | 1 | 2012 | 30 | 0.120 |
Why?
|
| Task Performance and Analysis | 2 | 2007 | 812 | 0.120 |
Why?
|
| Trypsinogen | 1 | 2012 | 84 | 0.120 |
Why?
|
| Immunity | 1 | 2019 | 957 | 0.120 |
Why?
|
| Causality | 2 | 2016 | 1137 | 0.120 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2015 | 1135 | 0.120 |
Why?
|
| Patient Preference | 1 | 2020 | 856 | 0.110 |
Why?
|
| Diseases in Twins | 2 | 2004 | 459 | 0.110 |
Why?
|
| Databases, Genetic | 3 | 2011 | 1807 | 0.110 |
Why?
|
| Membrane Glycoproteins | 2 | 2017 | 3812 | 0.110 |
Why?
|
| Health Care Costs | 5 | 2009 | 3152 | 0.110 |
Why?
|
| Claudins | 1 | 2012 | 108 | 0.110 |
Why?
|
| Trypsin | 1 | 2012 | 540 | 0.110 |
Why?
|
| Psychometrics | 4 | 2013 | 2966 | 0.110 |
Why?
|
| Receptors, Immunologic | 2 | 2017 | 1482 | 0.110 |
Why?
|
| Linear Models | 5 | 2017 | 5986 | 0.110 |
Why?
|
| Genetic Heterogeneity | 3 | 2011 | 749 | 0.110 |
Why?
|
| Receptor, EphA1 | 1 | 2011 | 19 | 0.110 |
Why?
|
| Risk Assessment | 6 | 2021 | 23284 | 0.110 |
Why?
|
| Menarche | 1 | 2014 | 485 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2007 | 3934 | 0.110 |
Why?
|
| Probability | 1 | 1997 | 2474 | 0.110 |
Why?
|
| Australia | 1 | 2014 | 1276 | 0.100 |
Why?
|
| Monomeric Clathrin Assembly Proteins | 1 | 2010 | 23 | 0.100 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 1994 | 761 | 0.100 |
Why?
|
| Brain Diseases | 1 | 2020 | 1530 | 0.100 |
Why?
|
| Adolescent Development | 1 | 2014 | 284 | 0.100 |
Why?
|
| Psychotic Disorders | 3 | 2018 | 2800 | 0.100 |
Why?
|
| Receptors, Complement 3b | 1 | 2010 | 149 | 0.100 |
Why?
|
| Clusterin | 1 | 2010 | 70 | 0.100 |
Why?
|
| Membrane Proteins | 3 | 2011 | 8072 | 0.100 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2013 | 461 | 0.100 |
Why?
|
| Prospective Studies | 12 | 2021 | 50597 | 0.100 |
Why?
|
| Phenotype | 7 | 2020 | 16306 | 0.100 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2014 | 1988 | 0.100 |
Why?
|
| Heat-Shock Proteins | 1 | 2014 | 889 | 0.090 |
Why?
|
| Body Weight | 1 | 2021 | 4680 | 0.090 |
Why?
|
| Time Factors | 10 | 2021 | 41038 | 0.090 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2011 | 312 | 0.090 |
Why?
|
| Microglia | 1 | 2017 | 1160 | 0.090 |
Why?
|
| Adult | 25 | 2022 | 211041 | 0.090 |
Why?
|
| Models, Psychological | 3 | 2009 | 823 | 0.090 |
Why?
|
| Heterozygote | 3 | 2007 | 2780 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 3 | 2005 | 4592 | 0.090 |
Why?
|
| Home Health Aides | 1 | 2008 | 15 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2000 | 3075 | 0.090 |
Why?
|
| Positron-Emission Tomography | 4 | 2018 | 6170 | 0.090 |
Why?
|
| Statistics as Topic | 3 | 2011 | 2402 | 0.090 |
Why?
|
| Incidence | 5 | 2021 | 20320 | 0.090 |
Why?
|
| Brain Chemistry | 1 | 2012 | 1019 | 0.090 |
Why?
|
| Logistic Models | 8 | 2021 | 13468 | 0.080 |
Why?
|
| Patient Selection | 1 | 2021 | 4306 | 0.080 |
Why?
|
| Statistics, Nonparametric | 5 | 2008 | 2945 | 0.080 |
Why?
|
| Severity of Illness Index | 10 | 2014 | 16008 | 0.080 |
Why?
|
| Leisure Activities | 1 | 2009 | 294 | 0.080 |
Why?
|
| Area Under Curve | 1 | 2012 | 1688 | 0.080 |
Why?
|
| ROC Curve | 2 | 2014 | 3518 | 0.080 |
Why?
|
| Brain Mapping | 6 | 2011 | 6545 | 0.080 |
Why?
|
| Hormone Replacement Therapy | 1 | 2013 | 732 | 0.080 |
Why?
|
| Lipids | 1 | 2019 | 3246 | 0.080 |
Why?
|
| Self-Assessment | 1 | 2009 | 390 | 0.080 |
Why?
|
| Orthopedic Procedures | 1 | 2017 | 1278 | 0.080 |
Why?
|
| alpha Catenin | 1 | 2007 | 43 | 0.080 |
Why?
|
| Prevalence | 8 | 2021 | 14712 | 0.080 |
Why?
|
| Hormones | 1 | 2011 | 855 | 0.080 |
Why?
|
| Physical Chromosome Mapping | 1 | 2007 | 189 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2005 | 466 | 0.080 |
Why?
|
| Brain Ischemia | 1 | 2021 | 3260 | 0.080 |
Why?
|
| Gene Dosage | 2 | 2012 | 1271 | 0.080 |
Why?
|
| Hip Fractures | 1 | 2014 | 867 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2005 | 389 | 0.080 |
Why?
|
| Advisory Committees | 1 | 2011 | 759 | 0.080 |
Why?
|
| Asthma | 2 | 2006 | 5850 | 0.080 |
Why?
|
| Pattern Recognition, Visual | 3 | 2007 | 830 | 0.070 |
Why?
|
| Carrier Proteins | 2 | 2014 | 5141 | 0.070 |
Why?
|
| Pneumonia | 2 | 2015 | 2080 | 0.070 |
Why?
|
| Database Management Systems | 1 | 2007 | 286 | 0.070 |
Why?
|
| Nuclear Proteins | 2 | 2000 | 5982 | 0.070 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 1 | 2007 | 306 | 0.070 |
Why?
|
| Twin Studies as Topic | 1 | 2005 | 105 | 0.070 |
Why?
|
| 3' Untranslated Regions | 2 | 2005 | 526 | 0.070 |
Why?
|
| Sterol O-Acyltransferase | 1 | 2005 | 57 | 0.070 |
Why?
|
| Immunity, Innate | 1 | 2017 | 2937 | 0.070 |
Why?
|
| Neuregulin-1 | 1 | 2005 | 141 | 0.070 |
Why?
|
| Eating | 2 | 2022 | 1443 | 0.070 |
Why?
|
| Cytoskeletal Proteins | 1 | 2011 | 1421 | 0.070 |
Why?
|
| Cause of Death | 1 | 2015 | 3497 | 0.070 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2008 | 1178 | 0.070 |
Why?
|
| Cathepsin D | 2 | 2001 | 66 | 0.070 |
Why?
|
| Cross-Cultural Comparison | 1 | 2008 | 648 | 0.060 |
Why?
|
| Postmenopause | 1 | 2013 | 2405 | 0.060 |
Why?
|
| African Americans | 1 | 2020 | 5118 | 0.060 |
Why?
|
| Data Collection | 3 | 2012 | 3276 | 0.060 |
Why?
|
| Natural Language Processing | 2 | 2022 | 936 | 0.060 |
Why?
|
| Europe | 2 | 2020 | 3104 | 0.060 |
Why?
|
| Clinical Trials as Topic | 2 | 2013 | 8024 | 0.060 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 2709 | 0.060 |
Why?
|
| Delusions | 1 | 2005 | 298 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2007 | 3984 | 0.060 |
Why?
|
| Hallucinations | 1 | 2005 | 356 | 0.060 |
Why?
|
| Terminology as Topic | 2 | 2006 | 1620 | 0.060 |
Why?
|
| Regression Analysis | 4 | 2011 | 6451 | 0.060 |
Why?
|
| Syndrome | 2 | 2006 | 3177 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2012 | 3179 | 0.060 |
Why?
|
| Focus Groups | 1 | 2007 | 1228 | 0.060 |
Why?
|
| Lipoproteins, LDL | 1 | 2005 | 660 | 0.060 |
Why?
|
| Executive Function | 1 | 2011 | 1307 | 0.060 |
Why?
|
| Movement Disorders | 1 | 2005 | 424 | 0.060 |
Why?
|
| Public Health | 1 | 2014 | 2363 | 0.060 |
Why?
|
| Thrombolytic Therapy | 1 | 2012 | 2163 | 0.050 |
Why?
|
| Epidemiologic Methods | 1 | 2007 | 1346 | 0.050 |
Why?
|
| Homozygote | 2 | 2020 | 1849 | 0.050 |
Why?
|
| Amyloidogenic Proteins | 1 | 2022 | 91 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2011 | 8968 | 0.050 |
Why?
|
| Sulfonylurea Compounds | 1 | 2022 | 189 | 0.050 |
Why?
|
| Home Care Services | 1 | 2008 | 592 | 0.050 |
Why?
|
| Aniline Compounds | 2 | 2017 | 953 | 0.050 |
Why?
|
| Delivery of Health Care | 2 | 2022 | 4810 | 0.050 |
Why?
|
| Insulysin | 1 | 2000 | 52 | 0.050 |
Why?
|
| Receptors, LDL | 1 | 2004 | 548 | 0.050 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2000 | 57 | 0.050 |
Why?
|
| Mathematical Computing | 1 | 2001 | 147 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2011 | 2046 | 0.050 |
Why?
|
| Software | 5 | 2006 | 4345 | 0.050 |
Why?
|
| Drug Repositioning | 1 | 2022 | 205 | 0.050 |
Why?
|
| Disability Evaluation | 1 | 2008 | 1829 | 0.050 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2003 | 555 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2012 | 3696 | 0.050 |
Why?
|
| Medical Informatics | 1 | 2007 | 736 | 0.050 |
Why?
|
| Hyperthyroidism | 1 | 2002 | 284 | 0.050 |
Why?
|
| Patient Care | 1 | 2006 | 610 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3097 | 0.050 |
Why?
|
| Sensitivity and Specificity | 4 | 2014 | 14836 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2011 | 4169 | 0.050 |
Why?
|
| Computer Simulation | 3 | 2007 | 6048 | 0.050 |
Why?
|
| Information Dissemination | 2 | 2021 | 1089 | 0.050 |
Why?
|
| Motivation | 1 | 2009 | 1868 | 0.050 |
Why?
|
| Genetic Variation | 2 | 2012 | 6666 | 0.050 |
Why?
|
| State Medicine | 1 | 2021 | 202 | 0.050 |
Why?
|
| Analysis of Variance | 3 | 2008 | 6530 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2017 | 7994 | 0.050 |
Why?
|
| Intracranial Thrombosis | 1 | 2000 | 124 | 0.050 |
Why?
|
| Autopsy | 2 | 2014 | 990 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 10857 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2001 | 412 | 0.050 |
Why?
|
| Societies, Medical | 1 | 2011 | 3776 | 0.050 |
Why?
|
| Apolipoproteins | 1 | 2021 | 303 | 0.050 |
Why?
|
| Germany | 1 | 2001 | 791 | 0.040 |
Why?
|
| Brief Psychiatric Rating Scale | 2 | 2008 | 108 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2005 | 2680 | 0.040 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2010 | 3418 | 0.040 |
Why?
|
| Thiazoles | 2 | 2017 | 1510 | 0.040 |
Why?
|
| Gene Expression | 1 | 2012 | 8014 | 0.040 |
Why?
|
| Ultrasonic Therapy | 1 | 2000 | 241 | 0.040 |
Why?
|
| Antidepressive Agents | 1 | 2011 | 2813 | 0.040 |
Why?
|
| Presenilin-2 | 1 | 1998 | 110 | 0.040 |
Why?
|
| Meat | 1 | 2021 | 556 | 0.040 |
Why?
|
| Narration | 1 | 2020 | 203 | 0.040 |
Why?
|
| Introns | 1 | 2000 | 1015 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2014 | 12366 | 0.040 |
Why?
|
| Reference Standards | 1 | 2021 | 992 | 0.040 |
Why?
|
| Siblings | 3 | 2007 | 806 | 0.040 |
Why?
|
| Panic Disorder | 2 | 2002 | 612 | 0.040 |
Why?
|
| Magnetics | 1 | 2000 | 645 | 0.040 |
Why?
|
| Organ Size | 2 | 2017 | 2317 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 3562 | 0.040 |
Why?
|
| Hypothyroidism | 1 | 2002 | 650 | 0.040 |
Why?
|
| Genetic Counseling | 1 | 2000 | 577 | 0.040 |
Why?
|
| Medical Records | 1 | 2022 | 1410 | 0.040 |
Why?
|
| Survival Analysis | 3 | 2007 | 10507 | 0.040 |
Why?
|
| Reading | 1 | 2021 | 546 | 0.040 |
Why?
|
| Dysthymic Disorder | 1 | 1996 | 75 | 0.040 |
Why?
|
| Hospitals, University | 2 | 2009 | 582 | 0.040 |
Why?
|
| Institutionalization | 2 | 2007 | 92 | 0.040 |
Why?
|
| Prognosis | 6 | 2017 | 28919 | 0.040 |
Why?
|
| Genes | 1 | 2000 | 1977 | 0.040 |
Why?
|
| Ethylene Glycols | 1 | 2017 | 161 | 0.040 |
Why?
|
| Blood Pressure Determination | 1 | 2019 | 607 | 0.040 |
Why?
|
| Mothers | 1 | 2006 | 1991 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2003 | 1778 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2011 | 3266 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 1999 | 989 | 0.040 |
Why?
|
| Disclosure | 1 | 2022 | 732 | 0.040 |
Why?
|
| Independent Living | 1 | 2019 | 536 | 0.030 |
Why?
|
| New Jersey | 1 | 2015 | 280 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2021 | 1592 | 0.030 |
Why?
|
| Massachusetts | 2 | 2021 | 8712 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2017 | 15053 | 0.030 |
Why?
|
| Life Expectancy | 1 | 2021 | 1116 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2020 | 2328 | 0.030 |
Why?
|
| Video Recording | 1 | 2020 | 949 | 0.030 |
Why?
|
| Secondary Prevention | 1 | 2021 | 1505 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 2007 | 373 | 0.030 |
Why?
|
| Presenilin-1 | 1 | 1998 | 645 | 0.030 |
Why?
|
| Nerve Net | 1 | 2006 | 2138 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2006 | 2290 | 0.030 |
Why?
|
| Age Distribution | 1 | 2020 | 2876 | 0.030 |
Why?
|
| Fiji | 1 | 2013 | 47 | 0.030 |
Why?
|
| Pennsylvania | 1 | 2015 | 651 | 0.030 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2017 | 465 | 0.030 |
Why?
|
| Energy Intake | 1 | 2021 | 2136 | 0.030 |
Why?
|
| DNA | 3 | 2003 | 7172 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2000 | 1481 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 7487 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 2 | 2021 | 5235 | 0.030 |
Why?
|
| Memory, Short-Term | 1 | 2020 | 935 | 0.030 |
Why?
|
| Dietary Fats | 1 | 2021 | 2042 | 0.030 |
Why?
|
| Psychiatry | 1 | 2005 | 1597 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2005 | 3507 | 0.030 |
Why?
|
| Smoking | 2 | 2008 | 8612 | 0.030 |
Why?
|
| Self Report | 2 | 2014 | 3397 | 0.030 |
Why?
|
| Inflammation | 1 | 2012 | 10019 | 0.030 |
Why?
|
| Bayes Theorem | 2 | 2011 | 1994 | 0.030 |
Why?
|
| Family Health | 3 | 2004 | 1276 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2017 | 2926 | 0.030 |
Why?
|
| Evoked Potentials | 1 | 2018 | 1031 | 0.030 |
Why?
|
| Databases, Bibliographic | 1 | 2012 | 130 | 0.030 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2021 | 1155 | 0.030 |
Why?
|
| Sweden | 1 | 2015 | 1290 | 0.030 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2014 | 228 | 0.030 |
Why?
|
| Health Status | 2 | 2021 | 4015 | 0.030 |
Why?
|
| Treatment Outcome | 4 | 2010 | 61932 | 0.030 |
Why?
|
| Monte Carlo Method | 2 | 2011 | 1301 | 0.030 |
Why?
|
| Verbal Learning | 1 | 2014 | 476 | 0.030 |
Why?
|
| Multivariate Analysis | 3 | 2008 | 12447 | 0.030 |
Why?
|
| Association | 1 | 2011 | 55 | 0.030 |
Why?
|
| Morbidity | 1 | 1996 | 1690 | 0.030 |
Why?
|
| Visual Perception | 1 | 2020 | 1401 | 0.030 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2014 | 568 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2005 | 3885 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2020 | 13274 | 0.030 |
Why?
|
| Multifactorial Inheritance | 1 | 2018 | 1130 | 0.030 |
Why?
|
| Anxiety Disorders | 1 | 2002 | 2567 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2014 | 6765 | 0.020 |
Why?
|
| Adolescent | 7 | 2018 | 84718 | 0.020 |
Why?
|
| Chromosome Segregation | 1 | 2011 | 229 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2022 | 2734 | 0.020 |
Why?
|
| Acute Disease | 1 | 2000 | 7158 | 0.020 |
Why?
|
| Socioeconomic Factors | 3 | 2008 | 7644 | 0.020 |
Why?
|
| Insurance Claim Review | 1 | 2014 | 736 | 0.020 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2004 | 3565 | 0.020 |
Why?
|
| Wechsler Scales | 1 | 2009 | 268 | 0.020 |
Why?
|
| DNA Mutational Analysis | 2 | 2009 | 4317 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2005 | 4615 | 0.020 |
Why?
|
| Residence Characteristics | 2 | 2011 | 1969 | 0.020 |
Why?
|
| Cleft Lip | 1 | 2013 | 418 | 0.020 |
Why?
|
| Health Behavior | 1 | 2021 | 2576 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2010 | 792 | 0.020 |
Why?
|
| Sex Factors | 2 | 2014 | 10566 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2000 | 4466 | 0.020 |
Why?
|
| Mental Disorders | 2 | 2005 | 6395 | 0.020 |
Why?
|
| Quality of Life | 1 | 2009 | 11594 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2008 | 308 | 0.020 |
Why?
|
| Prosopagnosia | 1 | 2008 | 54 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 9774 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2013 | 987 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2009 | 371 | 0.020 |
Why?
|
| Confusion | 1 | 2009 | 261 | 0.020 |
Why?
|
| Personality Assessment | 1 | 2009 | 653 | 0.020 |
Why?
|
| Multigene Family | 1 | 2011 | 1125 | 0.020 |
Why?
|
| Comorbidity | 3 | 2009 | 10339 | 0.020 |
Why?
|
| Mental Health | 1 | 2021 | 2602 | 0.020 |
Why?
|
| Technetium Tc 99m Exametazime | 1 | 2006 | 82 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 1994 | 1260 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2000 | 18748 | 0.020 |
Why?
|
| Orthopedic Equipment | 1 | 2006 | 24 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2016 | 4883 | 0.020 |
Why?
|
| Syncope | 1 | 2009 | 432 | 0.020 |
Why?
|
| Hypokinesia | 1 | 2005 | 17 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 1996 | 2510 | 0.020 |
Why?
|
| Muscle Rigidity | 1 | 2005 | 36 | 0.020 |
Why?
|
| Borderline Personality Disorder | 1 | 1992 | 718 | 0.020 |
Why?
|
| Dysarthria | 1 | 2005 | 54 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2005 | 12005 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2010 | 1336 | 0.020 |
Why?
|
| Schizophrenic Psychology | 1 | 1992 | 1670 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2017 | 8720 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 5045 | 0.020 |
Why?
|
| Receptors, Oxidized LDL | 1 | 2004 | 5 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2021 | 71483 | 0.020 |
Why?
|
| Behavioral Symptoms | 1 | 2006 | 166 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2007 | 873 | 0.020 |
Why?
|
| Scavenger Receptors, Class E | 1 | 2004 | 18 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2017 | 14215 | 0.020 |
Why?
|
| Calcium Channels | 1 | 2008 | 657 | 0.020 |
Why?
|
| Dominance, Cerebral | 1 | 2006 | 660 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2010 | 2920 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2009 | 1513 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2007 | 987 | 0.020 |
Why?
|
| Mutation | 2 | 2012 | 29262 | 0.020 |
Why?
|
| Twins, Dizygotic | 1 | 2004 | 239 | 0.020 |
Why?
|
| Length of Stay | 1 | 2017 | 6257 | 0.020 |
Why?
|
| Young Adult | 3 | 2018 | 55940 | 0.020 |
Why?
|
| Death | 1 | 2007 | 573 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 1993 | 2716 | 0.020 |
Why?
|
| Professional Practice | 1 | 2005 | 330 | 0.010 |
Why?
|
| Boston | 1 | 2016 | 9402 | 0.010 |
Why?
|
| Overweight | 1 | 2014 | 2205 | 0.010 |
Why?
|
| Twins, Monozygotic | 1 | 2004 | 465 | 0.010 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2005 | 236 | 0.010 |
Why?
|
| Genetics, Population | 1 | 2008 | 1003 | 0.010 |
Why?
|
| Drug Therapy | 1 | 2006 | 518 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2006 | 1580 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2008 | 1652 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2005 | 681 | 0.010 |
Why?
|
| RNA | 1 | 2012 | 2680 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2007 | 1823 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 2005 | 952 | 0.010 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2005 | 568 | 0.010 |
Why?
|
| Butyrylcholinesterase | 1 | 2000 | 25 | 0.010 |
Why?
|